Characterization of mortality from cardiovascular diseases: Cuba, 2013-2022
DOI:
https://doi.org/10.56294/saludcyt20251588Keywords:
mortality, cardiovascular diseases, CubaAbstract
Introduction: Cardiovascular diseases are the main cause of death in Cuba and the world. Statistics management contributes to identifying areas of greater risk and need, allows the effective allocation of resources for the prevention and treatment of these diseases and facilitates the implementation of programs to reduce morbidity and mortality. Objective: To characterize the mortality from cardiovascular diseases in Cuba, in the 2013-2022 decade. Methods: An ecological study was carried out. Statistical health yearbooks published from 2014 to 2023 were reviewed. The gross rates of mortality from heart and brain diseases were considered in all ages, according to sex and years of life potentially lost by those causes. Mortality rates adjusted by age and the number of deaths were taken into account by the main cardiovascular diseases and their distribution by age group. Results: A tendency to increase the gross rates of mortality from cardiovascular diseases was evidenced. Mortality rates adjusted by age showed a similar tendency. Heart diseases stood out as responsible for a greater number of deaths and potentially lost years. Mortality rates for cardiovascular diseases were higher in male sex and the number of deceased increase in correspondence with the increase in age. Conclusions: It is necessary to evaluate and rethink current strategies in cardiovascular prevention and develop new guidelines that guarantee adequate balance between effective primary prevention and quality medical assistance.
References
1. GBD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet [Internet]. 2018 [access 03/01/2025];392(10159):1736-1788. Available from: https://doi.org/10.1016/S0140-6736(18)322003-7
2. World Health Organization. Improving hypertension control in 3 million people: country experiences of programme development and implementation [Internet]. Geneva: WHO [Internet]. 2020 [access 02/06/2024]. ISBN: 9789240012714 Available from: https://iris.who.int/handle/10665/336019
3. Ordunez P, Tajer C, Gaziano T, Rodríguez YA, Rosende A, Jaffe MG. La aplicación HEARTS: una herramienta clínica para la gestión del riesgo cardiovascular y la hipertensión en atención primaria de salud. Rev Panam Salud Pública [Internet]. 2022 [acceso 20/03/2025];46:e46. Disponible en: https://doi.org/10.26633/RPSP.2022.46
4. OECD/The World Bank. Mortalidad por enfermedades cardiovasculares. In: Health at a Glance: Latin America and the Caribbean 2020. Paris: OECD Publishing [Internet]. 2020 [acceso 03/09/2023] p. 72-73. Disponible en: https://doi.org/10.1787/f09e3793-ess
5. Organización Panamericana de la Salud. Las ENT de un vistazo: Mortalidad de las enfermedades no transmisibles y prevalencia de sus factores de riesgo en la Región de las Américas. Washington, D.C.:OPS [Internet]. 2019. Disponible en: https://iris.paho.org/handle/10665.2/51572
6. Martinez R, Soliz P, Mujica OJ, Reveiz L, Campbell NRC, Ordunez P. The slowdown in the reduction rate of premature mortality from cardiovascular diseases puts the Americas at risk of achieving SDG 3.4: A population trend analysis of 37 countries from 1990 to 2017. J Clin Hypertens (Greenwich) [Internet]. 2020 [access 02/06/2024];22(8):1296-1309. Disponible en: https://doi.org/10.1111/jch.13922
7. Dueñas Herrera AF, Armas Rojas NB, Henry Vera G, Martínez Fernández CR. Mortalidad Prematura por Enfermedades Cardiovasculares en Cuba. Rev Cuba Cardiol Cir Cardiovasc [Internet]. 2018 [acceso 20/03/2025];24(4):420-6. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/819
8. Ordúñez García PO, Cooper RS, Espinosa Brito AD, Iraola Ferrer MD, Bernal Muñoz JL, La Rosa Linares Y. Enfermedades cardiovasculares en Cuba: determinantes para una epidemia y desafíos para la prevención y control. Rev Cubana Salud Pública [Internet]. 2005 [acceso 20/03/2025];31(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662005000400002&lng=es
9. Revueltas-Agüero M, Benítez-Martínez M, Hinojosa-Álvarez MC, Venero-Fernández S, Molina-Esquivel E, Betancourt-Bethencourt JA. Caracterización de la mortalidad por enfermedades cardiovasculares: Cuba, 2009-2018. AMC [Internet]. 2021 [acceso 20/03/2025];25(1): e7707. ISSN 1025-0255. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552021000100003&lng=es
10. Organización Panamericana de la Salud. Clasificación estadística internacional de enfermedades y problemas relacionados con la salud, décima revisión (CIE-10). Washington, D.C.: OPS [Internet]. 1995 [acceso 03/03/2025]. ISBN: 92 75 31554 X Disponible en: https://www.apps.who.int
11. Şahin M, Aybek E. Jamovi: An Easy to Use Statistical Software for the Social Scientists. Int J Assess Tools Educ [Internet]. 2019 [acceso 03/03/2025];670–92. Available from: https://eric.ed.gov/?id=EJ1243495
12. Landrove-Rodríguez O, Morejón-Giraldoni A, Venero-Fernández S, Suárez-Medina R, Almaguer-López M, Pallarols-Mariño E, et al. Enfermedades no transmisibles: factores de riesgo y acciones para su prevención y control en Cuba. Rev Panam Salud Publica [Internet]. 2018;42:e23. Disponible en: https://doi.org/10.26633/RPSP.2018.23
13. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, et al. ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European heart journal [Internet]. 2021 [access 03/03/2025];42(34):3227-3337. Available from: https://doi.org/10.1093/eurheartj/ehab484
14. Viera AJ, Reamy BV Jr. Cardiovascular Disease Prevention: Risk Assessment. FP Essent [Internet]. 2022 [access 11/01/2023]; 520:8-14. PMID: 36069717. Available from: https://pubmed.ncbi.nlm.nih.gov/36069717/
15. Grillo Martín M, Mezquia de Pedro N, González García S. Tablas de predicción de riesgo cardiovascular empleadas en Cuba. Rev Cuba Cardiol Cir Cardiovasc [Internet]. 2023 [acceso 14/08/2024];29(1) Disponible en: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1408
16. Colectivo de autores. Enfermedades no transmisibles en Cuba. [Internet]. La Habana: Editorial Ciencias Médicas; 2022. Disponible en http://www.bvscuba.sld.cu/libro/enfermedades-no-transmisibles-en-cuba
17. Revueltas-Agüero M, Molina-Esquivel E, Suárez-Medina R, Bonet-Gorbea M, Varona-Pérez P, Benítez-Martínez M. La hipertensión arterial en Cuba según la Encuesta Nacional de Salud 2018-2019. AMC [Internet]. 2022 [acceso 20/03/2025];26:e9239. ISSN 1025-0255. Disponible en: https://revistaamc.sld.cu/index.php/amc/article/view/9239
18. Revueltas Agüero M, Molina Esquivel E, Benítez Martínez M, Hinojosa Álvarez MC, Venero Fernández S, Betancourt Bethencourt JA. Caracterización de la prevalencia y mortalidad por hipertensión arterial en Cuba, decenio 2009- 2018. Rev haban cienc méd. 2021 [acceso 10/08/2024];20(2):e3457. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3457
19. Bonet M, Varona P, La Rosa MC, García RG, Suárez R, Arcia N, et al. III Encuesta nacional de factores de riesgo y actividades preventivas de enfermedades no trasmisibles. Cuba 2010-2011. Habana: Editorial Ciencias Médicas; 2014. ISBN: 978-959-212-894-1
20. Ministerio de Salud Pública. Anuario Estadístico de Salud 2019. Dirección de Registros Médicos y Estadísticas de Salud. La Habana 2020. ISSN: versión electrónica 1561-4433.
Published
Issue
Section
License
Copyright (c) 2025 Marielys Grillo Martín, Noydelis Miranda Lores, Damian Valdés Santiago (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
